
Hdglim M 2mg/500mg Tablet SR
Marketer
Medrix Labs Private Limited
Salt Composition
Glimepiride (2mg) + Metformin (500mg)
Overview Hdglim M 2mg/500mg Tablet SR
Glimepiride/Metformin 2mg/500mg extended-release tablets are classified as antidiabetic agents. This dual-action medication treats type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision can elevate glucose levels, increasing risks of kidney complications, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect. Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to counteract them. Regular meals and carrying a fast-acting glucose source (e.g., sugary snacks or juice) are preventive measures. Alcohol consumption should be limited due to its potential to worsen hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is also a potential side effect. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.
Uses of Hdglim M 2mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Hdglim M 2mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Hdglim M 2mg/500mg Tablet SR whole; do not break, crush, or chew it. Administer this extended-release tablet with a meal.
Common Side effects of Hdglim M 2mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Hdglim M 2mg/500mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the entire tablet whole; avoid chewing, crushing, or fracturing it. Hdglim M 2mg/500mg Extended-Release Tablets should be administered with a meal.
How Hdglim M 2mg/500mg Tablet SR works:
The extended-release tablet, Hdglim M 2mg/500mg SR, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Hdglim M 2mg/500mg SR tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Hdglim M 2mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Extended-release Hdglim M 2mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.
KidneyCAUTION
Patients with kidney impairment should use Hdglim M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is necessary. Hdglim M 2mg/500mg SR tablets are contraindicated in individuals with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.
LiverCAUTION
Individuals with liver impairment should use Hdglim M 2mg/500mg Tablet SR cautiously. Dosage modifications may be necessary for this medication. Physician consultation is advised. A low initial dose of Hdglim M 2mg/500mg Tablet SR is typically prescribed for those with mild to moderate liver disease; however, its use is contraindicated in cases of severe liver disease.
What if you forget to take Hdglim M 2mg/500mg Tablet SR :
Should you forget to take your Hdglim M 2mg/500mg Tablet SR, ingest it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Hdglim M 2mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Diabetes Treatment |
